论文信息 - Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma - 字舞流文

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

G. Salles | A. Zelenetz | S. Horwitz | A. Intlekofer | H. Schöder | E. Drill | A. Dogan | P. Hamlin | M. Palomba | M. Matasar | C. Moskowitz | J. Yahalom | Anita Kumar | A. Noy | D. Straus | A. Moskowitz | G. von Keudell | L. Falchi | E. Joffe | G. Pongas | S. Vardhana | O. Lahoud | C. Owens | P. Caron | G. Shah | W. Blouin | C. Batlevi | A. Hamilton | William Johnson | H. Hancock | I. Rodriguez-Rivera | N. Galasso | N. Ganesan | Brielle Liotta | L. Pérez | T. Davey | Sunyoung Ryu | S. Sohail | A. Santarosa | Rachel Neuman | Christina Y Lee | Beatriz Wills Sanin | Gottfried von Keudell | Colette N Owens | Ildefonso Rodriguez-Rivera | W. Johnson | B. W. Sanin